Welcome to the international HTA database

Showing [23806 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	C1-esterase inhibitor (Berinert®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Bariatric surgery for obese patients with co-morbidities: a review of clinical effectiveness, cost-effectiveness, and guidelines
2013	HAYES, Inc.	Laser therapy for psoriasis
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Obstetric early warning systems
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Appropriateness of CT imaging to support the diagnosis of stroke: a review of the clinical evidence
2013	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	Study of adherence to Recombinant Growth Hormone treatment of children with a GH deficiency: contributions to treatment control and economic impact
2013	NIHR Health Technology Assessment programme	Clinical and economic evaluation of laparoscopic surgery compared with medical management for gastro-oesophageal reflux disease: 5-year follow-up of multicentre randomised trial (the REFLUX trial)
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Controlled medication agreements for opioid use in chronic pain
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Linagliptin/metformin (Jentadueto®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	O-Arm technology in spinal, neurological, orthopedic, or trauma surgery settings: clinical effectiveness and benefits and harms to patients and hospital staff
2013	HAYES, Inc.	Maggot therapy for nonhealing wounds
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Systematic reviews of robotic surgery in obstetrics and gynecology
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Linagliptin-metformin (Jentadueto - Boehringer Ingelheim (Canada) Ltd.) indication: type 2 diabetes mellitus
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Cognitive and procedural skills of aging physicians
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Perampanel (Fycompa®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Intraoperative monitoring during spinal or neurological surgeries: clinical effectiveness and guidelines
2013	HAYES, Inc.	Percutaneous pulmonary valve implantation for right ventricular outflow tract defects
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Specialized geriatric care for hospitalized inpatients
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Perampanel (Fycompa - Eisai Ltd.) indication: epilepsy, partial-onset seizures
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Synthetic fleece (Polartec) attire: update
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Aclidinium bromide (Eklira® Genuair®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Indigenous knowledge for mental illness and chronic disease: clinical effectiveness and guidelines
2013	HAYES, Inc.	Photodynamic therapy for head and neck cancer
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Management of patients after the removal of an indwelling urinary catheter
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Azilsartan Medoxomil (Edarbi - Takeda Canada Inc.) indication: mild to moderate essential hypertension
2013	Andalusian Health Technology Assessment Area (AETSA)	[Hemodynamic monitoring techniques in the intensive care units]
2013	NIHR Health Technology Assessment programme	Cancer of Oesophagus or Gastricus - New Assessment of Technology of Endosonography (COGNATE): report of pragmatic randomised trial
2013	Agency for Healthcare Research and Quality (AHRQ)	Epoetin and darbepoetin for managing anemia in patients undergoing cancer treatment: comparative effectiveness update
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Community health workers
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Adalimumab (Humira®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Management of coronary artery disease in primary and community care: guidelines
2013	HAYES, Inc.	Photoscreening for the detection of amblyopia risk factors in children
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Nurse-directed protocols for removal of indwelling urinary catheters
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Distance consultation for chronic, non-healing, lower extremity wounds: clinical evidence
2013	NIHR Health Technology Assessment programme	AESOPS: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of opportunistic screening and stepped care interventions for older hazardous alcohol users in primary care
2013	Agency for Healthcare Research and Quality (AHRQ)	Childhood obesity prevention programs: comparative effectiveness review and meta-analysis
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Intravenous or rectal acetaminophen for post-operative pain
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Ceftaroline fosamil (Zinforo®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Heating standards for magnetic resonance conditional medical devices: clinical evidence
2013	HAYES, Inc.	Platelet function assays for patients on antiplatelet therapy undergoing cardiac surgery
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Plasma vaporization for the treatment of benign prostatic hypertrophy: clinical and cost-effectiveness, and safety
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Disinfecting caps and antimicrobial locks for reducing blood stream infections associated with central venous catheters
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Ingenol mebutate (Picato®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Screening tools compared to parental concern for identifying speech and language delays in preschool children: a review of the diagnostic accuracy
2013	HAYES, Inc.	Prophylactic oophorectomy for the prevention of ovarian cancer
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Use of surgical masks in the operating room: a review of the clinical effectiveness and guidelines
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Relationship between hemoglobin A1c levels and complications after elective hip and knee surgery
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Darunavir (Prezista®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	GreenLight laser for the treatment of benign prostatic hypertrophy: clinical and cost-effectiveness, and safety
2013	HAYES, Inc.	Pyrocarbon proximal interphalangeal and metacarpophalangeal joint implants
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Cleansing of the cervix prior to hysterosalpingogram: clinical evidence and guidelines
2013	NIHR Health Technology Assessment programme	Dabigatran for the prevention of stroke and systemic embolism in atrial fibrillation: A NICE single technology appraisal
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Esophageal temperature measurement to prevent complications of catheter ablation
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Ferumoxytol (Rienso®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Community-based programs to improve early childhood health outcomes: guidelines and recommendations
2013	HAYES, Inc.	Risk-reducing (prophylactic) mastectomy
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	CPAP treatment for adults with obstructive sleep apnea: review of the clinical and cost-effectiveness and guidelines
2013	NIHR Health Technology Assessment programme	The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Hourly rounding and other interventions to improve patient satisfaction associated with responsiveness
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Lapatinib (Tyverb®)
2013	NIHR Health Technology Assessment programme	Does short cycle antiretroviral therapy impact on inflammation, immune activation, thrombogenesis and CD4 cell dynamics?
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Non-steroidal anti-inflammatory drugs for pain: comparative clinical and cost-effectiveness
2013	HAYES, Inc.	Transanal hemorrhoidal dearterialization
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Dressing materials for the treatment of pressure ulcers in patients in long-term care facilities: a review of the comparative clinical effectiveness and guidelines
2013	Malaysian Health Technology Assessment (MaHTAS)	X Collar versus conventional cervical collar
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Securement devices for peripherally inserted central venous catheters (PICCs) and Midline catheters
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Ulipristal acetate (Esmya®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Management of chronic obstructive pulmonary disease in primary and community care: guidelines
2013	HAYES, Inc.	Transcatheter aortic valve implantation for aortic stenosis
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Suboxone versus methadone for the treatment of opioid dependence: a review of the clinical and cost-effectiveness
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Adalimumab (Humira®)
2013	HAYES, Inc.	Trigger point injections for myofascial pain
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Comparison of the Ankle Brachial Pressure Index (ABI) doppler with the pocket doppler with plethysmography probe in the assessment of arterial disease in diabetic patients: clinical and cost-effectiveness
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Tenofovir disoproxil fumarate (Viread®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Optimal in-hospital umbilical cord care for newborns: clinical evidence and guidelines
2013	HAYES, Inc.	Umbilical cord blood stem cell transplantation for hematological and lymphoid malignancies in adults
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Medication administration via metered dose inhalers and aerochambers versus nebulizers for adult patients: clinical effectiveness
2013	Malaysian Health Technology Assessment (MaHTAS)	Ultraviolet Germicidal Irradiation (UVGI) indoor purifier – an update
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Tenofovir disoproxil fumarate (Viread®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Extracorporeal circuit for patients undergoing hemodialysis: safety
2013	HAYES, Inc.	Umbilical cord blood stem cell transplantation for hematological cancers and nonmalignant disorders in children
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Group care for chronic disease management: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2013	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Systematic review on needs for medical devices for older people
2013	National Institute for Health and Care Excellence (NICE)	EXOGEN ultrasound bone healing system for long bone fractures with non-union or delayed healing. NICE medical technologies guidance 12
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Adalimumab (Humira®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Peripherally inserted central catheter-associated mast cell activation syndrome: clinical evidence
2013	HAYES, Inc.	Vagus nerve stimulation for depression
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Needle or open fasciotomy for dupuytren
2013	Haute Autorite de sante (HAS)	[Laser treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia]
2013	Malaysian Health Technology Assessment (MaHTAS)	Symptoms checker
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Nepafenac (Nevanac®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Mold prevention for hospital bed mattresses: clinical effectiveness and guidelines
2013	HAYES, Inc.	Video Electrencephalogram (VEEG) for the diagnosis and treatment of epilepsy in children
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Medication assessment alerts for in-hospital medication management: clinical evidence and guidelines
2013	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Breast prosthesis implantation for reconstructive and cosmetic surgery: a rapid review
2013	Haute Autorite de sante (HAS)	[Clinical utility of the measurement of vitamin D]
2013	Institute of Health Economics (IHE)	Total prosthetic replacement of the temporomandibular joint: a rapid evidence assessment and economic analysis
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Supraglottic airway devices in out-of-hospital settings: clinical evidence and guidelines
2013	HAYES, Inc.	Video Electroencephalogram (VEEG) for diagnosis and management of epilepsy in adults
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Peer support for diabetes, heart disease and HIV/AIDS: a review of the clinical effectiveness, cost-effectiveness, and guidelines